2017-03-24,Lifshitz & Miller LLP Announces Investigation Of Air Methods Corporation, Fortress Investment Group LLC, Galena Biopharma, Inc., Ionis Pharmaceuticals, Inc., LMI Aerospace, Inc., Lumos Networks Corp., Silver Bay Realty Trust Corp. And TerraForm Global, Inc.
2017-03-17,Galena Biopharma Presents Positive Final GALE-301 (E39) Phase 1/2a Clinical Trial Data
2017-03-15,Galena Biopharma Reports Fourth Quarter And Year End 2016 Financial Results And Provides A Corporate Update
2017-03-09,Galena Biopharma Engages Canaccord Genuity To Advise On Strategic Alternatives
2017-02-26,INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Galena Biopharma, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
2017-02-23,How to Dig Deep for Value in These Exuberant Markets
2017-02-23,Value Investors Have to Go Deeper
2017-02-22,Investor Alert: Kaplan Fox Announces Investigation Of Galena Biopharma Inc.
2017-02-21,Galena Biopharma Board Of Directors Appoints Stephen F. Ghiglieri As Interim Chief Executive Officer
2017-02-20,GALE FRAUD NOTICE: Rosen Law Firm Reminds Galena Biopharma, Inc. Investors Of Important Deadline In Class Action - GALE
2017-02-15,Glancy Prongay & Murray LLP Files Securities Class Action Lawsuit Against Galena BioPharma, Inc.
2017-02-13,Galena Biopharma Announces Closing Of Public Offering Of Common Stock And Warrants
2017-02-13,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Notifies Investors Of Class Action Against Galena Biopharma, Inc. (GALE) & Lead Plaintiff Deadline: April 14, 2017
2017-02-13,EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit Against Galena Biopharma, Inc.
2017-02-10,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Galena Biopharma Inc. And Encourages Investors To Contact The Firm
2017-02-10,SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Galena Biopharma, Inc. - GALE
2017-02-10,IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Galena Biopharma Inc. And Encourages Investors To Contact The Firm
2017-02-10,SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation Of Galena Biopharma, Inc. (GALE)
2017-02-10,EQUITY ALERT: Rosen Law Firm Announces Investigation Of Securities Claims Against Galena Biopharma, Inc. - GALE
2017-02-08,Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments
2017-02-08,Galena Biopharma Announces Pricing Of Public Offering Of Common Stock And Warrants
2017-02-07,Galena Biopharma Announces Proposed Public Offering Of Common Stock And Warrants
2017-02-06,How to Expertly Trade Monday's Most Active Stocks -- AMD, Newell Brands, Hasbro and More
2017-02-06,Galena Biopharma Reports Positive Outcome From The Data Safety Monitoring Board On The Two NeuVax™ (nelipepimut-S) Clinical Trials In Combination With Trastuzumab
2017-01-31,Galena Sacks CEO Amid Escalating Criminal Probe Into Fentanyl Drug Marketing
2017-01-31,Galena Biopharma Announces The Resignation Of Its President And Chief Executive Officer And The Evaluation Of Strategic Alternatives
2017-01-05,Galena Biopharma To Provide Corporate And Clinical Update And 2017 Outlook During Presentation At Biotech Showcase 2017
2016-12-28,Post-Trump Rally Stalls as Dow Jones Slips Further From 20,000 Mark
2016-12-28,Stocks Slump Continues With All S&P 500 Sectors in Negative Territory
2016-12-28,Midday Report: Stocks Snatch Earlier Gains as Dow Moves Away From 20,000 Mark
2016-12-28,Stocks Turn Negative, Prolonging Dow's Trek Toward 20,000
2016-12-28,Galena Biopharma Confirms Regulatory Pathway For GALE-401 (Anagrelide Controlled Release)
2016-12-22,What Adam Feuerstein Got Right and Wrong About Biotech Stocks in 2016
2016-12-14,Galena Biopharma Announces The Phase 2 Clinical Trial Of NeuVax™ (nelipepimut-S) In Ductal Carcinoma In Situ (DCIS) Is Open For Enrollment And Screening Patients
2016-12-12,Galena Biopharma Presented Two Posters At The San Antonio Breast Cancer Symposium
2016-12-05,Galena Biopharma Inc. Presentation Now Available For On-Demand Viewing
2016-11-30,Galena Biopharma To Present Two Posters At The San Antonio Breast Cancer Symposium
2016-11-22,Galena Biopharma Inc. To Webcast, Live, At VirtualInvestorConferences.com December 1
2016-11-14,Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data At The Society For Immunotherapy Of Cancer Conference 2016
2016-11-09,Galena Biopharma Reports Third Quarter 2016 Financial Results And Provides A Corporate Update
2016-11-03,Galena Biopharma Appoints Stephen F. Ghiglieri As Executive Vice President And Chief Financial Officer
2016-10-31,Galena Biopharma Announces Reverse Stock Split
2016-10-31,Research Reports On Biotech Equities -- Mast Therapeutics, Array BioPharma, Galena Biopharma, And Clovis Oncology
2016-10-26,Galena Biopharma To Report Third Quarter 2016 Financial Results And Provide A Corporate Update On Wednesday, November 9, 2016
2016-10-20,Galena Biopharma Presents GALE-301/GALE-302 Phase 1b Data At The American College Of Surgeons Clinical Congress 2016
2016-10-10,Galena Biopharma To Present NeuVax™ (nelipepimut-S) Plus Trastuzumab Interim Safety Data At The European Society For Medical Oncology (ESMO) 2016 Congress
2016-09-29,Galena Biopharma To Present NeuVax™ (nelipepimut-S) Interim Safety Data At The European Society For Medical Oncology (ESMO) 2016 Congress
2016-09-27,Galena Biopharma Presents GALE-301 Folate Binding Protein Expression Data At The CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference
2016-09-20,Galena Biopharma To Present At The Sachs Associates 16th Annual Biotech In Europe Forum
2016-09-15,Notable Thursday Option Activity: GALE, ETSY, TKAI
2016-09-14,Galena Biopharma To Present At The 2016 Aegis Growth Conference
2016-09-13,Galena Biopharma Presents Preclinical NeuVax™ (nelipepimut-S) Data In Ovarian And Pancreatic Cancer At The Progress In Vaccination Against Cancer (PIVAC) Conference
2016-09-12,Galena Biopharma Expands GALE-401 Intellectual Property Protection With Patent Issuance In Japan
2016-09-09,Galena Biopharma To Present At The Rodman & Renshaw 18th Annual Global Investment Conference
2016-08-09,Galena Biopharma Reports Second Quarter 2016 Financial Results And Provides A Corporate Update
2016-07-26,Galena Biopharma To Report Second Quarter 2016 Financial Results And Provide A Corporate Update On Tuesday, August 9, 2016
2016-07-13,Galena Biopharma Announces Closing Of Registered Direct Offering
2016-07-08,Galena Biopharma To Host Webcast And Conference Call Today
2016-07-08,Galena Biopharma Announces Pricing Of Registered Direct Offering
2016-06-29,2 Big-Volume Stocks to Add to Your Buy List -- Plus 5 Risky Ones to Avoid
2016-06-29,Galena Craters on Breast Cancer Vaccine Study Failure
2016-06-29,Galena Biopharma Discontinues NeuVax™ (nelipepimut-S) Phase 3, PRESENT Interim Analysis Based On Independent Data Monitoring Committee Recommendation
2016-06-21,First Week of GALE August 19th Options Trading
2016-06-13,Galena Biopharma Presents GALE-401 Combined Safety Data At The European Hematology Association 21st Congress
2016-06-10,Galena Biopharma Receives Two Orphan Drug Designations For GALE-301 And GALE-301/GALE-302
2016-06-07,SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Galena Biopharma, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors
2016-06-06,Galena Biopharma Presents GALE-301 Phase 1/2a Primary Analysis At The American Society Of Clinical Oncology Annual Meeting 2016
2016-06-01,Galena (GALE) Stock Soared Today, Breast Cancer Treatment Received 'Fast Track' Designation
2016-06-01,7 Big-Volume Stocks to Trade for Big Gains
2016-06-01,Why Galena Biopharma (GALE) Stock Is Spiking Today
2016-06-01,Galena Biopharma Receives Fast Track Designation For NeuVax™ (nelipepimut-S) PRESENT Clinical Trial
2016-05-24,Noteworthy Tuesday Option Activity: GALE, ANF, VEEV
2016-05-24,Galena Biopharma To Present At The Sachs Associates 2nd Annual Immuno-Oncology BD&L And Investment Forum
2016-05-19,Galena Biopharma To Present GALE-401 Combined Safety Data At The European Hematology Association 21st Congress
2016-05-18,Galena Biopharma To Present The GALE-301 Phase 1/2a Primary Analysis At The American Society Of Clinical Oncology Annual Meeting 2016
2016-05-10,Galena Biopharma Reports First Quarter 2016 Financial Results And Provides A Corporate Update
2016-04-27,Galena Biopharma To Report First Quarter 2016 Financial Results And Provide A Corporate Update On Tuesday, May 10, 2016
2016-04-26,Galena Biopharma Appoints Mary Ann Gray, Ph.D., To Its Board Of Directors
2016-04-19,Galena Biopharma Presents GALE-301/GALE-302 Clinical Booster Data At The American Association For Cancer Research (AACR) Annual Meeting
2016-04-05,Commit To Purchase Galena Biopharma At $1, Earn 36.1% Annualized Using Options
2016-04-03,Biotech Stock Mailbag: Intercept, Acadia, Keryx, Galena
2016-03-29,Here&rsquo;s Why Galena Biopharma (GALE) Stock is Spiking Today
2016-03-29,Galena Biopharma Phase 3 PRESENT Clinical Trial With NeuVax™ (nelipepimut-S) Achieves 70th Qualifying Disease Free Survival Event
2016-03-22,Notable Tuesday Option Activity: GALE, BPI, GMED
2016-03-11,Galena Not Named Target of Federal Criminal Probe Into Painkiller Use
2016-03-11,Galena Biopharma Corrects Error In Form 10-K
2016-03-10,Galena Biopharma Reports Fourth Quarter And Year End 2015 Financial Results And Provides A Corporate Update
2016-03-07,Galena Biopharma To Present At The 28th Annual ROTH Conference
2016-02-26,Galena Biopharma To Report Fourth Quarter And Year End 2015 Financial Results And Provide A Corporate Update On Thursday, March 10, 2016
2016-02-17,Notable Wednesday Option Activity: GALE, WSTC, SEAS
2016-02-16,Galena Biopharma Announces Proposed Settlement Of Derivative Litigation
2016-02-08,Galena Biopharma Announces Notice Of Allowance Of U.S. Patent For NeuVax™ (nelipepimut-S)
2016-02-02,Galena Biopharma To Present At The BIO CEO & Investor Conference
2016-01-21,Galena Biopharma Presents Observational Study Data In Gastric Cancer Patients At The ASCO 2016 Gastrointestinal Cancers Symposium
2016-01-13,Galena Biopharma Provides 2016 Outlook
2016-01-11,Galena Biopharma To Present At NobleCon12 - Noble Financial Capital Markets' Twelfth Annual Investor Conference
2016-01-09,2016 Biotech Stock Prediction: It's Going to Be a Bummer Year, Folks
2016-01-07,Galena Biopharma Announces Pricing Of Public Offering Of Common Stock And Warrants
2016-01-06,Galena Biopharma Announces Proposed Public Offering Of Common Stock And Warrants
2015-12-24,Galena Biopharma Announces A Change To Its Board Of Directors
2015-12-18,Galena Biopharma To Sell Zuplenz® (ondansetron) Oral Soluble Film, Completing Divestiture Of Commercial Operations
2015-12-11,Galena Biopharma Announces Departure Of Chief Financial Officer
2015-12-08,Galena Biopharma Presents Final GALE-401 Phase 2 Clinical Data At The 57th American Society Of Hematology (ASH) Annual Meeting And Exposition
2015-12-04,Galena Biopharma Announces Settlement Of Securities Class Action And Shareholder Derivative Lawsuits
2015-11-30,Galena Biopharma To Present At The Oppenheimer 26th Annual Healthcare Conference
2015-11-20,Galena Biopharma Completes Divestiture Of Abstral(R) (fentanyl) Sublingual Tablets As Part Of Strategic Focus On Its Immunotherapy Pipeline
2015-11-12,Galena Biopharma (GALE) Stock Rating Upgraded at Oppenheimer
2015-11-10,Galena Biopharma (GALE) Stock Declines on Earnings Miss
2015-11-09,Galena Biopharma Reports Third Quarter 2015 Financial Results And Announces Exclusive Focus On Its Clinical Development Programs With Planned Divestiture Of The Commercial Business
2015-11-09,Galena Biopharma Presents GALE-302 Preliminary Immunologic Data Optimizing GALE-301 At The Society For Immunotherapy Of Cancer (SITC) 30th Anniversary Annual Meeting
2015-11-06,Galena Biopharma To Present Final GALE-401 Phase 2 Clinical Data At The 57th American Society Of Hematology (ASH) Annual Meeting And Exposition
2015-10-30,Galena Biopharma Appoints Bijan Nejadnik, M.D., As Executive Vice President And Chief Medical Officer
2015-10-26,Galena Biopharma To Report Third Quarter Financial Results And Provide Business Update On Monday, November 9, 2015
2015-10-22,Galena Biopharma To Present GALE-302 Preliminary Immunological Data Optimizing GALE-301, And The Phase 2 NeuVax(TM) Data Impact On Cancer Survivorship At Two Upcoming Medical Conferences
2015-09-30,Galena Biopharma Collaborates With The National Cancer Institute On A Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) In Ductal Carcinoma In Situ Patients
2015-09-28,Galena Biopharma Presents Positive GALE-301 Phase 2a Clinical Trial Data At The European Cancer Congress 2015
2015-09-14,Galena Biopharma To Present GALE-301 Phase 2a Clinical Trial Data At The European Society For Medical Oncology (ESMO) European Cancer Congress 2015
2015-09-01,Galena Biopharma To Present At Two Upcoming Healthcare Investment Conferences
2015-08-31,Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches Of Fiduciary Duty
2015-08-24,Galena Biopharma Announces Independent Data Safety Monitoring Committee Recommends Reduction Of Cardiac Toxicity Monitoring For NeuVax(TM) PRESENT Trial
2015-08-06,Galena Biopharma Reports Second Quarter 2015 Financial Results
2015-08-06,August 6 Premarket Briefing: 10 Things You Should Know
2015-07-29,Galena Biopharma Launches Zuplenz(R) (ondansetron) Oral Soluble Film
2015-07-28,Galena Biopharma To Report Second Quarter Financial Results On Thursday, August 6, 2015
2015-07-21,First Week Of GALE September 18th Options Trading
2015-06-23,Interesting GALE Call Options For August 21st
2015-06-15,Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Phase 2 Data At The European Hematology Association 20th Congress
2015-06-10,Galena Biopharma (GALE) Is Today's Dead Cat Bounce Stock
2015-06-08,3 Big Stocks on Traders' Radars -- and What to Do With Them
2015-06-08,Galena Biopharma (GALE) Highlighted As Weak On High Volume
2015-06-04,Strong On High Volume: Galena Biopharma (GALE)
2015-05-28,Galena Biopharma To Present At The Sachs Immuno-Oncology BD&L And Investment Forum
2015-05-27,Galena Biopharma (GALE) Stock Spikes on Promising Cancer Vaccine Study Results
2015-05-27,Galena Biopharma Announces Publication Of Two Abstracts At The 2015 American Society Of Clinical Oncology Annual Meeting
2015-05-26,3 Biotech Stocks Under $10 to Trade for Breakouts
2015-05-22,Galena Biopharma To Present GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial Data At The European Hematology Association 20th Congress
2015-05-07,Galena Biopharma Reports First Quarter 2015 Financial Results
2015-05-07,May 7 Premarket Briefing: 10 Things You Should Know
2015-04-24,5 Stocks Ready for Breakouts
2015-04-23,Galena Biopharma To Report First Quarter Financial Results On Thursday, May 7, 2015
2015-04-14,Galena Biopharma Completes Over-Enrollment Of NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial
2015-04-10,Galena Biopharma Announces Closing Of Over-Allotment Option, Increasing Total Gross Proceeds To $43.7 Million
2015-03-31,Galena Biopharma To Present At The 14th Annual Needham Healthcare Conference
2015-03-26,Galena Biopharma Expands Patient Population In NeuVax(TM) (nelipepimut-S) And Trastuzumab Phase 2b Combination Clinical Trial In HER2 1+/2+ Patients
2015-03-18,Galena Biopharma Announces Closing Of Public Offering Of Common Stock And Warrants
2015-03-13,3 Biotech Stocks on Traders' Radars: Technical Charts
2015-03-13,Galena Biopharma Announces Pricing Of Public Offering Of Common Stock And Warrants
2015-03-12,Galena Biopharma Announces Proposed Public Offering Of Common Stock And Warrants
2015-03-05,Galena Biopharma Reports Fourth Quarter And Year End 2014 Financial Results
2015-03-03,Galena Biopharma To Present At The 27th Annual ROTH Conference
2015-02-19,Galena Biopharma To Report Fourth Quarter And Year End 2014 Financial Results On Thursday, March 5, 2015
2015-02-09,Galena Biopharma Enrolls 700th Patient In NeuVax(TM) (nelipepimut-S) Phase 3 PRESENT Clinical Trial
2015-02-05,GALE March 27th Options Begin Trading
2015-02-05,Galena Biopharma Announces Orexo's Filing Of A Patent Infringement Lawsuit Against Actavis Concerning Abstral(R) (fentanyl) Sublingual Tablets In The U.S.
2015-01-28,Galena Biopharma To Present At The 17th Annual BIO CEO & Investor Conference
2015-01-20,Galena Biopharma Hires Joseph Lasaga As Vice President, Business Development And Alliance Management
2015-01-15,Galena Biopharma To Present At The Noble Financial Capital Markets 11th Annual Investor Conference
2015-01-14,Galena Biopharma (GALE) Is Weak On High Volume Today
2015-01-08,GALE February 27th Options Begin Trading
2015-01-08,Galena Biopharma Provides 2015 Outlook
2014-12-29,Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens
2014-12-19,Adam Feuerstein's 2014 Biotech Stock Report Card (No Grading on a Curve)
2014-12-15,Nominees for Absolute Worst Biotechnology CEOs of 2014 Are ...
2014-12-11,Galena Biopharma Presents HER2 Screening Data Including Preliminary Leica Bond Oracle(TM) Results From The Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial At The 2014 San Antonio Breast Cancer Symposium (SABCS)
2014-12-08,Galena Biopharma Presents GALE-401 (Anagrelide Controlled Release) Clinical Trial Data At The 56th American Society Of Hematology (ASH) Annual Meeting & Exposition
2014-12-05,Galena Biopharma To Present HER2 Screening Data From The Phase 3 NeuVax(TM) (nelipepimut-S) Clinical Trial At The 2014 San Antonio Breast Cancer Symposium (SABCS)
2014-12-02,Galena Biopharma Receives Notice Of Allowance Of U.S. Patent Application For GALE-401 (Anagrelide Controlled Release) Composition Of Matter
2014-12-01,Galena Biopharma To Present GALE-401 (Anagrelide Controlled Release) Phase 1 Clinical Trial Data At The 56th American Society Of Hematology (ASH) Annual Meeting & Exposition
2014-11-25,Galena Biopharma To Present At The Oppenheimer 25th Annual Healthcare Conference
2014-11-24,Galena, Shunned by Wall Street, Forced to Seek Pricey Vulture Financing
2014-11-20,Galena Biopharma Announces Purchase Agreement For Up To $55.0 Million With Lincoln Park Capital Fund, LLC
2014-11-18,Galena Biopharma Completes Enrollment In GALE-401 (Anagrelide Controlled Release) Phase 2 Clinical Trial
2014-11-13,Galena Biopharma To Present At The Stifel 2014 Healthcare Conference
2014-11-11,Galena Biopharma Doses First Patient In Phase 2 Clinical Trial With NeuVax(TM) (nelipepimut-S) In Combination With Herceptin(R) (trastuzumab) To Treat High-Risk HER2 3+ Or HER2 Gene-Amplified Breast Cancer Patients
2014-11-07,Galena Biopharma Presents GALE-301 (Folate Binding Protein Immunotherapy) Phase 2a Clinical Trial Data At The Society For Immunotherapy Of Cancer (SITC) 29th Annual Meeting
2014-11-04,Galena Biopharma To Present GALE-301 (Folate Binding Protein) Phase 2a Clinical Trial Data At The Society For The Immunotherapy Of Cancer (SITC) 29th Annual Meeting On Friday, November 7, 2014
2014-11-03,Galena Biopharma Reports Third Quarter 2014 Results
2014-10-27,Galena Biopharma To Report Third Quarter 2014 Financial Results On Monday, November 3, 2014
2014-10-24,Interesting GALE Put Options For December 20th
2014-10-14,Galena Biopharma Receives Notice Of Allowance Of Improvement Patent For NeuVax(TM) (nelipepimut-S) In Japan
